
Twist Bioscience
Synthetic DNA, silicon platform, gene synthesis
Twist manufactures synthetic DNA on silicon chips. It sells genes, oligonucleotide pools, NGS tools, and antibody services.
- Twist manufactures synthetic DNA on silicon chips at scale. Q3 FY2026 revenue: $56.6M, up 39% YoY.
- Main growth driver: AI-enabled drug discovery, triple-digit growth in FY2026 vs FY2025.
- Market leader in synthetic DNA supply for research and drug discovery.
twistbioscience.com↗ (opens twistbioscience.com)Company profile →
- Founded
- 201313 yrs
- Headquarters
- United States
- Status
- Public
- Valuation
- $12Bmarket capSep 2026
- Staff
- ~979Jan 2026
- Last round
- IPO · $105M2018
- Coverage
- 1 program · 1 updatelatest 3 Aug 2026checked 10 Oct
- People
- Emily M. LeproustCo-founder and CEOPatrick FinnPresident and Chief Operating Officer